Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Insulin Delivery Systems market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 14.1% during the forecast period.
This report presents the market size and development trends by detailing the Insulin Delivery Systems market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Insulin Delivery Systems market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Insulin Delivery Systems industry and will help you to build a panoramic view of the industrial development.
Insulin Delivery Systems Market, By Type:
Insulin syringes
Insulin pump
Insulin pens
Insulin jet injectors
Insulin Delivery Systems Market, By Application:
Hospitals
Specialty diabetic clinics
Retail channels
Some of the leading players are as follows:
Insulet
Novo Nordisk
West Pharma
Owen Mumford
Valeritas
Debiotech
Medtronic
Cellnovo
Dance Biopharm
Animas
InsuJet
MannKind
Beta Bionics
Roche, SHL Group
Ypsomed
SOOIL
Sanofi
Eli Lilly
Copernicus
Becton Dickinson
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Insulin Delivery Systems Market: Technology Type Analysis
-
4.1 Insulin Delivery Systems Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Insulin Delivery Systems Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Insulin syringes
4.3.2 Insulin pump
4.3.3 Insulin pens
4.3.4 Insulin jet injectors
5 Insulin Delivery Systems Market: Product Analysis
-
5.1 Insulin Delivery Systems Product Market Share Analysis, 2018 & 2026
-
5.2 Insulin Delivery Systems Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Insulin Delivery Systems Market: Application Analysis
-
6.1 Insulin Delivery Systems Application Market Share Analysis, 2018 & 2026
-
6.2 Insulin Delivery Systems Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Hospitals
6.3.2 Specialty diabetic clinics
6.3.3 Retail channels
7 Insulin Delivery Systems Market: Regional Analysis
-
7.1 Insulin Delivery Systems Regional Market Share Analysis, 2018 & 2026
-
7.2 Insulin Delivery Systems Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Insulet
9.1.1 Insulet Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Novo Nordisk
9.2.1 Novo Nordisk Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 West Pharma
9.3.1 West Pharma Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Owen Mumford
9.4.1 Owen Mumford Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Valeritas
9.5.1 Valeritas Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Debiotech
9.6.1 Debiotech Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Medtronic
9.7.1 Medtronic Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Cellnovo
9.8.1 Cellnovo Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Dance Biopharm
9.9.1 Dance Biopharm Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Animas
9.10.1 Animas Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 InsuJet
9.11.1 InsuJet Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 MannKind
9.12.1 MannKind Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 Beta Bionics
9.13.1 Beta Bionics Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 Roche, SHL Group
9.14.1 Roche, SHL Group Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
9.15 Ypsomed
9.15.1 Ypsomed Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis
9.16 SOOIL
9.16.1 SOOIL Company overview
9.16.2 Financial performance
9.16.3 Product benchmarking
9.16.4 Strategic initiatives
9.16.5 SWOT analysis
9.17 Sanofi
9.17.1 Sanofi Company overview
9.17.2 Financial performance
9.17.3 Product benchmarking
9.17.4 Strategic initiatives
9.17.5 SWOT analysis
9.18 Eli Lilly
9.18.1 Eli Lilly Company overview
9.18.2 Financial performance
9.18.3 Product benchmarking
9.18.4 Strategic initiatives
9.18.5 SWOT analysis
9.19 Copernicus
9.19.1 Copernicus Company overview
9.19.2 Financial performance
9.19.3 Product benchmarking
9.19.4 Strategic initiatives
9.19.5 SWOT analysis
9.20 Becton Dickinson
9.20.1 Becton Dickinson Company overview
9.20.2 Financial performance
9.20.3 Product benchmarking
9.20.4 Strategic initiatives
9.20.5 SWOT analysis
The List of Tables and Figures (Totals 71 Figures and 158 Tables)
Figure Insulin syringes Insulin Delivery Systems market, 2015 - 2026 (USD Million)
Figure Insulin pump Insulin Delivery Systems market, 2015 - 2026 (USD Million)
Figure Insulin pens Insulin Delivery Systems market, 2015 - 2026 (USD Million)
Figure Insulin jet injectors Insulin Delivery Systems market, 2015 - 2026 (USD Million)
Figure Hospitals market, 2015 - 2026 (USD Million)
Figure Specialty diabetic clinics market, 2015 - 2026 (USD Million)
Figure Retail channels market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Insulin Delivery Systems market, by country, 2015 - 2026 (USD Million)
-
Table North America Insulin Delivery Systems market, by type, 2015 - 2026 (USD Million)
-
Table North America Insulin Delivery Systems market, by product, 2015 - 2026 (USD Million)
-
Table North America Insulin Delivery Systems market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Insulin Delivery Systems market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Insulin Delivery Systems market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Insulin Delivery Systems market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Insulin Delivery Systems market, by type, 2015 - 2026 (USD Million)
-
Table Canada Insulin Delivery Systems market, by product, 2015 - 2026 (USD Million)
-
Table Canada Insulin Delivery Systems market, by application, 2015 - 2026 (USD Million)
-
Table Europe Insulin Delivery Systems market, by country, 2015 - 2026 (USD Million)
-
Table Europe Insulin Delivery Systems market, by type, 2015 - 2026 (USD Million)
-
Table Europe Insulin Delivery Systems market, by product, 2015 - 2026 (USD Million)
-
Table Europe Insulin Delivery Systems market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Insulin Delivery Systems market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Insulin Delivery Systems market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Insulin Delivery Systems market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Insulin Delivery Systems market, by type, 2015 - 2026 (USD Million)
-
Table Germany Insulin Delivery Systems market, by product, 2015 - 2026 (USD Million)
-
Table Germany Insulin Delivery Systems market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Insulin Delivery Systems market, by type, 2015 - 2026 (USD Million)
-
Table France Insulin Delivery Systems market, by product, 2015 - 2026 (USD Million)
-
Table France Insulin Delivery Systems market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Insulin Delivery Systems market, by type, 2015 - 2026 (USD Million)
-
Table Italy Insulin Delivery Systems market, by product, 2015 - 2026 (USD Million)
-
Table Italy Insulin Delivery Systems market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Insulin Delivery Systems market, by type, 2015 - 2026 (USD Million)
-
Table Spain Insulin Delivery Systems market, by product, 2015 - 2026 (USD Million)
-
Table Spain Insulin Delivery Systems market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Insulin Delivery Systems market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Insulin Delivery Systems market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Insulin Delivery Systems market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Insulin Delivery Systems market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Insulin Delivery Systems market, by type, 2015 - 2026 (USD Million)
-
Table China Insulin Delivery Systems market, by product, 2015 - 2026 (USD Million)
-
Table China Insulin Delivery Systems market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Insulin Delivery Systems market, by type, 2015 - 2026 (USD Million)
-
Table Japan Insulin Delivery Systems market, by product, 2015 - 2026 (USD Million)
-
Table Japan Insulin Delivery Systems market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Insulin Delivery Systems market, by type, 2015 - 2026 (USD Million)
-
Table India Insulin Delivery Systems market, by product, 2015 - 2026 (USD Million)
-
Table India Insulin Delivery Systems market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Insulin Delivery Systems market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Insulin Delivery Systems market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Insulin Delivery Systems market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Insulin Delivery Systems market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Insulin Delivery Systems market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Insulin Delivery Systems market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Insulin Delivery Systems market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Insulin Delivery Systems market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Insulin Delivery Systems market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Insulin Delivery Systems market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Insulin Delivery Systems market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Insulin Delivery Systems market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Insulin Delivery Systems market, by application, 2015 - 2026 (USD Million)
-
Table MEA Insulin Delivery Systems market, by country, 2015 - 2026 (USD Million)
-
Table MEA Insulin Delivery Systems market, by type, 2015 - 2026 (USD Million)
-
Table MEA Insulin Delivery Systems market, by product, 2015 - 2026 (USD Million)
-
Table MEA Insulin Delivery Systems market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Insulin Delivery Systems market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Insulin Delivery Systems market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Insulin Delivery Systems market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Insulin Delivery Systems market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Insulin Delivery Systems market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Insulin Delivery Systems market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Insulet Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novo Nordisk Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table West Pharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Owen Mumford Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Valeritas Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Debiotech Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Medtronic Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Cellnovo Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Dance Biopharm Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Animas Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table InsuJet Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table MannKind Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Beta Bionics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Roche, SHL Group Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Ypsomed Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table SOOIL Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sanofi Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Eli Lilly Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Copernicus Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Becton Dickinson Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
